Valuation: Ferozsons Laboratories Limited

Market Cap 17.53B 63.25M 55.16M 52.08M 47.29M 88.61M 6.07B 88.98M 624M 241M 3.09B 238M 232M 9.93B P/E 2024
15.9x
P/E 2025 21.8x
Enterprise Value 19.46B 70.25M 61.26M 57.84M 52.52M 98.41M 6.74B 98.82M 693M 267M 3.43B 264M 258M 11.03B EV / Sales 2024
0.93x
EV / Sales 2025 1x
Free-Float
72.55%
Yield 2024
1.2%
Yield 2025 1.03%
1 day+5.93%
1 week+0.56%
Current month-1.62%
1 month-5.39%
3 months-14.65%
6 months+11.40%
Current year-6.86%
1 week 311.2
Extreme 311.2
355
1 month 311.2
Extreme 311.2
384
Current year 293.01
Extreme 293.01
475
1 year 293.01
Extreme 293.01
475
3 years 136.85
Extreme 136.85
475
5 years 118
Extreme 118
475
10 years 60.33
Extreme 60.326387
631.94
Manager TitleAgeSince
Chief Executive Officer - 1998-12-31
Director of Finance/CFO - 2025-12-18
Director of Finance/CFO - -
Director TitleAgeSince
Director/Board Member - 1998-12-31
Director/Board Member - 1983-12-31
Director/Board Member - 2009-12-31
Change 5-day change 1-year change 3-year change Capi.($)
+5.93%+0.56%-16.09%+156.22% 51.81M
+0.04%+3.34%+51.12%+101.82% 1,027B
-0.09%+1.66%+55.02%+66.18% 651B
-0.02%+2.66%+18.91%+71.47% 467B
-1.22%+3.66%+36.44%+38.32% 350B
-0.79%+2.73%+19.03%+25.08% 268B
+0.58%+6.76%+11.13%+16.52% 257B
+1.55%+2.20%+39.81%+46.55% 205B
+0.79%+1.84%-28.27%-56.71% 190B
-0.52%+4.45%+32.12%+98.51% 187B
Average +0.77%+3.31%+21.92%+56.40% 360.22B
Weighted average by Cap. +0.23%+3.01%+35.17%+61.81%

Financials

2024 2025
Net sales 15.85B 57.22M 49.9M 47.11M 42.78M 80.16M 5.49B 80.49M 564M 218M 2.79B 215M 210M 8.98B 18.86B 68.06M 59.34M 56.04M 50.88M 95.34M 6.53B 95.73M 671M 259M 3.32B 256M 250M 10.68B
Net income 683M 2.47M 2.15M 2.03M 1.84M 3.45M 237M 3.47M 24.32M 9.38M 120M 9.26M 9.06M 387M 777M 2.8M 2.44M 2.31M 2.1M 3.93M 269M 3.94M 27.64M 10.67M 137M 10.53M 10.29M 440M
Net Debt 3.87B 13.97M 12.19M 11.51M 10.45M 19.58M 1.34B 19.66M 138M 53.19M 682M 52.5M 51.33M 2.19B 1.94B 7M 6.1M 5.76M 5.23M 9.8M 671M 9.84M 69M 26.63M 341M 26.28M 25.7M 1.1B
Logo Ferozsons Laboratories Limited
Ferozsons Laboratories Limited is a Pakistan-based pharmaceutical company. It is engaged in the importing, manufacturing and sale of pharmaceutical products and medical devices. The Company possesses brands in the areas of gastroenterology, hepatology, cardiology, and oncology, with a presence in endocrinology as well as mother and child health the diabetes space. Its segments include Ferozsons, BF Biosciences, and others. The Ferozsons segment is engaged in the import, manufacture, and sale of pharmaceutical products as well as import and sale of medical devices. The BF Biosciences segment is engaged in the import, manufacture, and sale of pharmaceutical products. The others segment is engaged in sale of pharmaceutical and other related products. The Company's subsidiaries include BF Biosciences Limited, which is engaged in the import, manufacturing, and sale of pharmaceutical products and Farmacia, which is engaged in the sale and distribution of medicines and other related products.
Employees
1,556
Date Price Change Volume
26-09-18 PKR 349.95 +5.93% 35,965
26-09-17 PKR 330.35 +3.70% 26,411
26-09-16 PKR 318.57 -0.32% 66,560
26-09-15 PKR 319.60 -2.81% 14,620
26-09-14 PKR 328.83 -5.51% 66,319

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. FEROZ Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!